These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9020371)

  • 1. Adhesion molecule CD11a/CD18-deficient Burkitt's lymphoma cells lack the transcript for the beta, but not the alpha, integrin subunit.
    Neira M; Rincon J; Arias H; Law SK; Patarroyo M
    Eur J Haematol; 1997 Jan; 58(1):32-9. PubMed ID: 9020371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells.
    Rincon J; Prieto J; Patarroyo M
    Int J Cancer; 1992 May; 51(3):452-8. PubMed ID: 1317364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence, or low expression, of leukocyte adhesion molecules CD11 and CD18 on Burkitt lymphoma cells.
    Patarroyo M; Prieto J; Ernberg I; Gahmberg CG
    Int J Cancer; 1988 Jun; 41(6):901-7. PubMed ID: 2897343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells.
    Weber S; Babina M; Feller G; Henz BM
    Scand J Immunol; 1997 May; 45(5):471-81. PubMed ID: 9160089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD; Murray RJ; Edwards CF; Rickinson AB
    J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
    Imreh MP; Zhang QJ; de Campos-Lima PO; Imreh S; Krausa P; Browning M; Klein G; Masucci MG
    Int J Cancer; 1995 Jul; 62(1):90-6. PubMed ID: 7601573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).
    Calender A; Cordier M; Billaud M; Lenoir GM
    Int J Cancer; 1990 Oct; 46(4):658-63. PubMed ID: 1698730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro.
    Tomeczkowski J; zur Stadt U; Reiter A; Welte K; Sykora KW
    Br J Haematol; 1997 May; 97(2):400-8. PubMed ID: 9163607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
    Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated human platelets express beta2 integrin.
    Philippeaux MM; Vesin C; Tacchini-Cottier F; Piguet PF
    Eur J Haematol; 1996 Mar; 56(3):130-7. PubMed ID: 8598231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
    Jilg W; Voltz R; Markert-Hahn C; Mairhofer H; Münz I; Wolf H
    Cancer Res; 1991 Jan; 51(1):27-32. PubMed ID: 1899042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.